Physicians' Cancer Chemotherapy Drug Manual 2012

Physicians' Cancer Chemotherapy Drug Manual 2012

by Edward Chu, Vincent T. DeVita Jr.
     
 
Completely revised and updated for 2012, the Physicians’ Cancer Chemotherapy Drug Manual is an up-to-date guide to the latest information on standard therapy and recent advances in the field. Written by world-class experts in clinical cancer therapeutics, this essential reference provides a complete, easy-to-use catalog of over 100 drugs and commonly used drug

Overview

Completely revised and updated for 2012, the Physicians’ Cancer Chemotherapy Drug Manual is an up-to-date guide to the latest information on standard therapy and recent advances in the field. Written by world-class experts in clinical cancer therapeutics, this essential reference provides a complete, easy-to-use catalog of over 100 drugs and commonly used drug regimens—both on- and off-label—for the treatment of all the major cancers.

Special features:
Revised to reflect rapid advances in the field, incorporating treatment strategies and new drugs like Abiraterone acetate, Eributin, Ipilimumab, Romidepsin, Sipuleucel-T, and Vandetanib.
A specific chapter focused on profiling antiemetic drug and antiemetic treatment regimens.
Diagrams of drug structures and pathways for many of the agents.
Offers a comprehensive discussion of clinical pharmacology, special considerations, indications, and dosages.
Covers toxicity and drug–drug interactions.
A section on chemotherapy regimens for all major cancers.
Provides an overview of the basic principles of cancer drug therapy.
Contains an easy to load and use CD version.

Editorial Reviews

Doody's Review Service
Reviewer: Kehinde Adekola, MBBS (Northwestern University Feinberg School of Medicine)
Description: This is a concise review of currently approved chemotherapeutic agents and biologic agents used in the treatment of cancer. It is an update of the 2011 edition, and includes four agents approved by the FDA since then.
Purpose: The purpose is to collect the chemotherapeutic and biologic agents currently used in clinical practice in one concise reference. This book also acts as a guide for practicing oncologists to existing chemotherapeutic agents, with information on toxicities and recommendations for dose modifications.
Audience: It rightly targets practicing oncologists, and is also an excellent resource for hematology/oncology fellows and oncology nurses. The contributors are among the leading experts in medical oncology.
Features: The book highlights the key principles of cancer chemotherapy, different chemotherapeutic regimens, and the settings in which they are used. The agents are covered in alphabetical order, with quick reviews of the mechanism of actions, pharmacokinetic, pharmacodynamics, toxicities and special considerations for the agents. There is also a chapter on agents used to manage chemotherapy-induced nausea and vomiting. A shortcoming is the absence of a table/diagram of the different drug classes showing in which group each of the agents belongs.
Assessment: This is an excellent and concise resource for hematologists/oncologists. This edition is justified, especially with the four new agents approved by the FDA in the last year.
Reviewer: Kehinde Adekola, MBBS(Northwestern University Feinberg School of Medicine)
Description: This is a concise review of currently approved chemotherapeutic agents and biologic agents used in the treatment of cancer. It is an update of the 2011 edition, and includes four agents approved by the FDA since then.
Purpose: The purpose is to collect the chemotherapeutic and biologic agents currently used in clinical practice in one concise reference. This book also acts as a guide for practicing oncologists to existing chemotherapeutic agents, with information on toxicities and recommendations for dose modifications.
Audience: It rightly targets practicing oncologists, and is also an excellent resource for hematology/oncology fellows and oncology nurses. The contributors are among the leading experts in medical oncology.
Features: The book highlights the key principles of cancer chemotherapy, different chemotherapeutic regimens, and the settings in which they are used. The agents are covered in alphabetical order, with quick reviews of the mechanism of actions, pharmacokinetic, pharmacodynamics, toxicities and special considerations for the agents. There is also a chapter on agents used to manage chemotherapy-induced nausea and vomiting. A shortcoming is the absence of a table/diagram of the different drug classes showing in which group each of the agents belongs.
Assessment: This is an excellent and concise resource for hematologists/oncologists. This edition is justified, especially with the four new agents approved by the FDA in the last year.

Product Details

ISBN-13:
9781449646837
Publisher:
Jones & Bartlett Learning
Publication date:
12/29/2011
Edition description:
Older Edition
Pages:
600
Product dimensions:
6.60(w) x 8.60(h) x 1.30(d)

Related Subjects

Customer Reviews

Average Review:

Write a Review

and post it to your social network

     

Most Helpful Customer Reviews

See all customer reviews >